A Clinical Trial on HB-Vac Activated-DCs Combined With Peg-IFN or NAs in CHB
A Clinical Trial on Hepatitis B Vaccine Activated-DCs Combined With Peg-interferon or Nucleotide Analogs in Chronic Hepatitis B
Sponsor: Ruijin Hospital
Listed as NCT01935635, this PHASE1/PHASE2 trial focuses on Chronic Hepatitis B and remains completed. Sponsored by Ruijin Hospital, it has been updated 7 times since 2015, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
-
Nov 2020 — Jan 2021 [monthly]
Completed PHASE1_PHASE2
Status: Unknown Status → Completed
-
May 2019 — Nov 2020 [monthly]
Unknown Status PHASE1_PHASE2
Status: Recruiting → Unknown Status
▶ Show 2 earlier versions
-
Jun 2018 — May 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Jan 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ruijin Hospital
- Second People's Hospital of Yunnan Province
- Third Affiliated Hospital, Sun Yat-Sen University
For direct contact, visit the study record on ClinicalTrials.gov .